Viemed Healthcare Q2 revenue rises 14.7%
Overview
Viemed Healthcare Q2 2025 net revenue rises 14.7% yr/yr to $63.1 mln
Net income for Q2 2025 jumps 115.1% yr/yr to $3.2 mln
Co repurchased 270,061 shares, signaling strategic capital use
Outlook
Viemed expects 2025 revenue between $271 mln and $277 mln
Company anticipates 2025 adjusted EBITDA of $59 mln to $62 mln
Revenue guidance increased due to Lehans acquisition impact
Result Drivers
PATIENT COUNT GROWTH - Increase in ventilator and PAP therapy patient counts contributed to revenue growth
EXPENSE LEVERAGING - Continued leveraging of expenses aided in meeting organic growth targets
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | $63.06 mln | ||
Q2 Net Income | $3.25 mln | ||
Q2 Gross Profit | $36.73 mln | ||
Q2 Income from Operations | $5.10 mln | ||
Q2 Pretax Profit | $4.96 mln |
Analyst Coverage
The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 17 three months ago
Press Release:
